Contract pharma services spanning biomarkers, APIs, formulations, and clinical supply
Almac Group operates a diversified contract manufacturing and clinical services platform for pharma development, with 7,800+ employees globally serving 600+ pharmaceutical companies. The tech stack is heavily weighted toward analytical instrumentation (HPLC, UPLC, LC-MS, qPCR) and legacy enterprise systems (Access, Excel, Vault, SCADA), reflecting a capital-intensive, compliance-driven business. Hiring is manufacturing-dominant (44 open roles) with a secondary ops focus, signaling operational scaling at existing sites rather than new capability buildout.
Notable leadership hires: Project Lead
Almac Group provides end-to-end contract services across drug discovery, development, and clinical supply for the pharmaceutical industry. The service portfolio spans biomarker discovery and companion diagnostics (CLIA lab), API and chemical synthesis (including potent and cytotoxic compounds), formulation and analytical development, and global clinical trial supply chain management. They also operate randomization software, eCOA systems, and manufacturing/packaging for both clinical and commercial phases. Operating across multiple geographies (US, UK, Ireland, Japan, Singapore), Almac services the full product lifecycle from preclinical through commercialization.
Analytical: HPLC, UPLC, LC-MS, qPCR. Enterprise/Lab systems: Microsoft Access, Vault, CDISC, GCP, Jira Service Management, SharePoint. Manufacturing control: SCADA, DCS, PLC. Also runs custom clinical tech platforms (IVRS, eCOA, IRT systems).
7,800+ employees globally, operating in 5,001–10,000 employee range. Privately held and financially secure with 55+ years in business.
Other companies in the same industry, closest in size